Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

PLUR Pluri Inc

Price (delayed)

$4.75

Market cap

$37.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.62

Enterprise value

$28.3M

Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented ...

Highlights
PLUR's debt has dropped by 100% since the previous quarter and by 100% year-on-year
The gross profit has soared by 62% YoY and by 14% from the previous quarter
The net income has declined by 4.3% since the previous quarter but it is up by 4.2% year-on-year
The gross margin has contracted by 47% YoY and by 25% from the previous quarter

Key stats

What are the main financial stats of PLUR
Market
Shares outstanding
7.83M
Market cap
$37.2M
Enterprise value
$28.3M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
30.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.37
Earnings
Revenue
$1.03M
Gross profit
$539,000
Operating income
-$21.59M
Net income
-$20.71M
EBIT
-$21.54M
EBITDA
-$21.27M
Free cash flow
-$18.22M
Per share
EPS
-$3.62
EPS diluted
-$3.62
Free cash flow per share
-$2.78
Book value per share
N/A
Revenue per share
$0.16
TBVPS
$5.7
Balance sheet
Total assets
$37.41M
Total liabilities
N/A
Debt
$0
Equity
N/A
Working capital
N/A
Liquidity
Debt to equity
N/A
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
0.42
Margins
EBITDA margin
-2,057.1%
Gross margin
52.1%
Net margin
-2,003.3%
Operating margin
-2,087.9%
Efficiency
Return on assets
-57.8%
Return on equity
N/A
Return on invested capital
-52.9%
Return on capital employed
N/A
Return on sales
-2,082.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PLUR stock price

How has the Pluri stock price performed over time
Intraday
-0.61%
1 week
6.5%
1 month
-1.45%
1 year
-15.63%
YTD
11.11%
QTD
10.47%

Financial performance

How have Pluri's revenue and profit performed over time
Revenue
$1.03M
Gross profit
$539,000
Operating income
-$21.59M
Net income
-$20.71M
Gross margin
52.1%
Net margin
-2,003.3%

PLUR financials

Pluri's operating margin has surged by 69% YoY and by 35% QoQ
PLUR's net margin has surged by 68% year-on-year and by 32% since the previous quarter
The gross profit has soared by 62% YoY and by 14% from the previous quarter
Pluri's revenue has soared by 53% from the previous quarter

Price vs fundamentals

How does PLUR's price correlate with its fundamentals

PLUR Price vs fundamentals

PLUR Earnings waterfall

PLUR Price vs fair value

Growth

What is Pluri's growth rate over time

PLUR growth chart

Valuation

What is Pluri stock price valuation
P/E
N/A
P/B
N/A
P/S
30.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.37

Valuation vs average

Price to earnings (P/E)

Pluri's EPS has increased by 12% YoY

Price to book (P/B)

Price to sales (P/S)

Pluri's revenue has soared by 53% from the previous quarter
PLUR's P/S is 43% below its last 4 quarters average of 52.6

Efficiency

How efficient is Pluri business performance
PLUR's return on invested capital has dropped by 65% year-on-year and by 21% since the previous quarter
Pluri's return on sales has surged by 64% YoY and by 32% QoQ
Pluri's return on assets has decreased by 16% YoY and by 3.4% QoQ

Dividends

What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PLUR.

Financial health

How did Pluri financials performed over time

Assets vs liabilities

The company's total assets rose by 21% QoQ and by 2.8% YoY

Debt vs equity

PLUR's debt has dropped by 100% since the previous quarter and by 100% year-on-year

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.